Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amicus Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
FOLD
Nasdaq
2830
amicusrx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amicus Therapeutics, Inc.
Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan
- Jun 25th, 2025 5:00 am
Amicus Therapeutics Publishes Positive PROPEL Study Data for Pompe Disease Treatment
- Jun 24th, 2025 10:45 am
New Strong Sell Stocks for June 3rd
- Jun 3rd, 2025 5:45 am
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
- Jun 3rd, 2025 5:00 am
Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025
- May 30th, 2025 5:00 am
3 High Growth Tech Stocks In The US Market
- May 21st, 2025 11:41 am
Is Amicus Therapeutics (FOLD) the Best Low Priced Biotech Stock to Buy Now?
- May 13th, 2025 6:51 am
Amicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
- May 7th, 2025 5:00 am
Amicus Therapeutics First Quarter 2025 Earnings: Misses Expectations
- May 4th, 2025 7:00 am
FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls
- May 2nd, 2025 11:18 am
Dimerix and Amicus to commercialise DMX-200 in US
- May 1st, 2025 8:44 am
Amicus Therapeutics (FOLD) Q1 Earnings and Revenues Lag Estimates
- May 1st, 2025 6:15 am
Amicus Therapeutics: Q1 Earnings Snapshot
- May 1st, 2025 5:17 am
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
- May 1st, 2025 5:00 am
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
- Apr 30th, 2025 5:12 pm
Earnings Preview: Y-mAbs Therapeutics, Inc. (YMAB) Q1 Earnings Expected to Decline
- Apr 29th, 2025 8:01 am
Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Apr 24th, 2025 8:01 am
Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
- Apr 23rd, 2025 10:57 am
Amicus Therapeutics to Report Q1 Earnings: What's in the Cards?
- Apr 23rd, 2025 7:25 am
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
- Apr 21st, 2025 5:00 am
Scroll